Mini Review on Laboratory Practices During Covid-19 Pandemic: From Microbiologists Perspective
Main Article Content
Abstract
Laboratory practices in a laboratory have changed worldwide due to the emergence of the COVID-19 pandemic. The changes occur concerning specimen collection, handling, transportation, processing, and disposal. Infection control practices are applied in all aspects, starting from specimen collection until the clinician gets the results. A retrospective review of laboratory practices used in a tertiary teaching hospital laboratory from microbiologists’ perspectives was performed, and the practices were compared with previously published articles.
Downloads
Article Details
References
WHO. Coronavirus disease (COVID-19) Situation Report – 195 [Internet]. 2020 [cited 2020 Aug 3]. p. 1–16. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations [Internet]. [cited 2020 Aug 3]. Available from: https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations
2020. Clinical management of COVID-19 [Internet]. 2020 [cited 2020 Aug 3]. p. 1–55. Available from: https://www.who.int/publications/i/item/clinical-management-of-covid-19
Laney DA, Germain DP, Oliveira JP, Burlina AP, Cabrera GH, Hong G-R, et al. Fabry disease and COVID-19: international expert recommendations for management based on real-world experience. Clin Kidney J [Internet]. 2020 Dec 28 [cited 2021 Jan 20];13(6):913–25. Available from: https://pubmed.ncbi.nlm.nih.gov/33391734/
Ministry of Health Malaysia. Annex 2e CLINICAL MANAGEMENT OF CONFIRMED COVID-19 CASE IN ADULT AND PAEDIATRIC [Internet].2020. Available from: https://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm/ANNEX-2E-CLINICAL-MANAGEMENT-OF-CONFIRMED-COVID-19-28122023.pdf
WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases Interim [Internet]. 2020. p. 1–6. Available from: https://www.who.int/publications/i/item/10665-331501
Basu A, Zinger T, Inglima K, Woo K, Atie O, Yurasits L, et al. Performance of Abbott ID NOW COVID-19 rapid nucleic acid amplification test in nasopharyngeal swabs transported in viral media and dry nasal swabs, in a New York City academic institution. J Clin Microbiol [Internet]. 2020 May 29 [cited 2020 Aug 3];58(8). Available from: https://pubmed.ncbi.nlm.nih.gov/32471894/
Medical Device Authority M of HM, Perubatan P, Co I M, Auth D, Kementerian R, Malaysia K. EDARAN SENARAI KIT PENGUJIAN COVID-19 (ANTIGEN, ANTIBODI DAN RT-PCR) YANG TELAH MENDAPAT KEPUTUSAN RECOMMENDED FOR USE DARIPADA JAWATANKUASA PENILAIAN PAKAR IVD PIHAK BERKUASA PERANTI PERUBATAN.
Tan W, Lu Y, Zhang J, Wang J, Dan Y, Tan Z. Viral Kinetics and Antibody Responses in Patients with COVID-19. 2020;
Sidiq Z, Hanif M, Dwivedi KK, Chopra KK. Benefits and limitations of serological assays in COVID-19 infection. Indian J Tuberc [Internet]. 2020 Dec 1 [cited 2021 Apr 18];67(4):S163–6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409828/
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review. 2020;2019.
Aiswarya D, Arumugam V, Dineshkumar T, Gopalakrishnan N, Moses Lamech T, Nithya G, et al. USE OF REMDESIVIR IN PATIENTS WITH COVID-19 ON HEMODIALYSIS- A STUDY OF SAFETY AND TOLERANCE. Kidney Int Reports [Internet]. 2020 Dec [cited 2021 Jan 20]; Available from: https://pubmed.ncbi.nlm.nih.gov/33354635/
FDA U. FDA Approves First Treatment for COVID-19 | FDA [Internet]. US FDA. 2020 [cited 2020 Nov 22]. p. 4. Available from: https://www. fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19
Thanh Le T, Andreadakis Z, Kumar A, Gómez Román R, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape [Internet]. Vol. 19, Nature reviews. Drug discovery. NLM (Medline); 2020 [cited 2020 Aug 3]. p. 305–6. Available from: https://pubmed.ncbi.nlm.nih.gov/32273591/
Prabhakar HKIMC. Clinical Synopsis of COVID-19. 2020.
CDC. Infographic: Biosafety Lab Levels | CDC [Internet]. 2018 [cited 2021 Feb 18]. Available from: https://www.cdc.gov/cpr/infographics/biosafety.htm
Kaufer AM, Theis T, Lau KA, Gray JL, Rawlinson WD. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent. Pathology [Internet]. 2020 Sep [cited 2020 Oct 20];Pathology. Available from: https://pubmed.ncbi.nlm.nih.gov/33070960/
WHO. Diagnostic testing for SARS-CoV-2 [Internet]. [cited 2020 Oct 20]. Available from: https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2
WHO. WHO-WPE-GIH-2021.1-eng. 2021;
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) [Internet]. 2020. p. 1–40. Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf
Zhang W, Du R-H, Li B, Zheng X-S, Yang X-L, Hu B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386–9.
Surveillance WHO, Sops A. Laboratory testing for 2019 novel coronavirus ( 2019-nCoV ) in suspected human cases Interim guidance. 2020;(January).
Berkeley Lovelace Jr, Noah Higgins-dunn WF. WHO considers ‘airborne precautions’ for medical staff after study shows coronavirus can survive in air. 16th March. 2020.
Licina A, Silvers A, Stuart RL. Use of powered air- purifying respirator (PAPR) by healthcare workers for preventing highly infectious viral diseases - A systematic review of evidence [Internet]. Vol. 9, Systematic Reviews. BioMed Central; 2020 [cited 2020 Oct 20]. p. 173. Available from: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01431-5
WHO. Packaging of Infectious Substances [Internet]. 2016. Available from: https://www.who.int/ihr/biosafety/Module_iii_packaging.pdf?ua=1
MOH Malaysia. Guidelines on the use of Deep Throat Saliva as another sample to perform Real Time RT-PCR for COVID-19. 2021.
L. Wyllie AFJ et al. Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2. 2020.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;497–506.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13.
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 ( COVID-19 ). 2020;2019(February):16–24.
Andersson M, Arancibia - Carcamo C, Auckland K, Baillie JK, Barnes E, Beneke T, et al. SARS-CoV-2 RNA detected in blood samples from patients with COVID-19 is not associated with infectious virus. medRxiv [Internet]. 2020 Jun 17 [cited 2021 Jan 20];2020.05.21.20105486. Available from: https://doi.org/10.1101/2020.05.21.20105486
Ketua Pengarah Kesihatan Malaysia. EDARAN GUIDELINE FOR COVID-19 RAPID MOLECULAR TESTING VERSION 1.0. 2021.
La Scola B, Le Bideau M, Andreani J, Hoang VT, Grimaldier C, Colson P, et al. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur J Clin Microbiol Infect Dis. 2020 Jun 1;39(6):1059–61.
CDC. Discontinuation of Transmission-Based Precautions and Disposition of Patients with SARS- CoV-2 Infection in Healthcare Settings | CDC [Internet]. 2021 [cited 2021 Feb 18]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html
MOH M. SURAT PEKELILING KETUA PENGARAH KESIHATAN MALAYSIA BIL.32021. 2021;
WHO. SARS-CoV-2 antigen-detecting rapid diagnostic tests. 2020.
CDC. Laboratory Biosafety and COVID-19: Questions and Answers. 19th March. 2020.
CDC. Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19). 31st March. 2020.
Laboratory biosafety guidance related to coronavirus disease 2019 ( COVID-19 ). Vol. 2019. 2020.
Salmuna ZN, Hasan SA, Shueb RH, Muhammad Faizal NFA. COVID-19 Pandemic: Impacts on Specimen Collection and Processing for Viral Respiratory Culture [Internet]. 2020 [cited 2021 Jan 20]. Available from: http://covid19.kk.usm.my/index.php/artikel/medical-professional/69-covid-19-pandemic-impacts-on-specimen-collection-and-processing-for-viral-respiratory-culture
Services H. Biosafety in Microbiological and Biomedical Laboratories. 2009;(December).
National Public Health Laboratory (NPHL) Malaysia grows SARS-CoV-2 virus in cell culture.
Pyke A, Mackay I, Moore F, Van Den Hurk A, Northill J, et al. Culture of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; f.2019-nCoV). protocols.io. doi:10.17504/protocols.io.bcduis6w
Kaye M, Druce J, Tran T, Kostecki R, Chibo D, Morris J, et al. SARS – associated Coronavirus Replication in Cell Lines. 2006;12(1).
CDC. List N: Disinfectants for Use Against SARS- CoV-2. 19 March. 2020.
Cleaning and disinfection of environmental surfaces in the context of COVID-19 [Internet]. [cited 2020 Aug 3]. Available from: https://www.who.int/publications/i/item/cleaning-and-disinfection-of-environmental-surfaces-inthe-context-of-covid-19
Ministry of Health Malaysia. Hypochlorous Acid for Indoor and Outdoor Disinfectant [Internet]. 2020. Available from: https://www.accessdata.fda.gov/scripts/fdcc/?set=FCN&id=1811
Chia PY, Coleman KK, Tan YK, Ong SWX, Gum M, Lau SK, et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat Commun [Internet]. 2020 Dec 1 [cited 2020 Oct 22];11(1):1–7. doi:10.1038/s41467-020-16670-2
Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 [Internet]. Vol. 382, New England Journal of Medicine. Massachussetts Medical Society; 2020 [cited 2020 Oct 22]. p. 1564–7. Available from: http://www.nejm.org/doi/10.1056/NEJMc2004973
CDC. eCR Now: COVID-19 Electronic Case Reporting for Healthcare Providers | CDC [Internet]. 2021 [cited 2021 Feb 21]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/electronic-case-reporting.html
Bates DW, Ebell M, Gotlieb E, Zapp J, Mullins HC. A proposal for electronic medical records in U.S. primary care. J Am Med Informatics Assoc [Internet]. 2003 [cited 2021 Feb 21];10(1):1–10. Available from: https://pubmed.ncbi.nlm.nih.gov/12509352/